Prevalence and Risk Factors of Erectile Dysfunction in Patients with Type 2 Diabetes Mellitus in Erbil-Iraq

Yahya Kamal  MohammedAli; Yousif Baha'addin  Ahmed

doi:10.56056/amj.2023.226

Authors

Yahya Kamal MohammedAli F.K.B.M.S (Int. Med), M.B.Ch.B. Lecturer, Department of Internal medicine, College of Medicine, Hawler Medical University
Yousif Baha'addin Ahmed M.B.Ch.B, MSc., Ph.D. Ass. Prof, Department of Internal medicine, College of Medicine, Hawler Medical University

DOI:

https://doi.org/10.56056/amj.2023.226

Keywords:

Diabetes, Erbil-Iraq, Erectile dysfunction, Prevalence, Risk factors

Abstract

Background and Objectives: Erectile dysfunction is a highly prevalent disease. It affects multiple aspects of health and can have a serious adverse effect on both the patients and their partners. Diabetes mellitus is a metabolic disorder associated with many chronic complications including erectile dysfunction. The aim of this study was to find out the prevalence and risk factors of erectile dysfunction in patients with type 2 diabetes mellitus.

Patients and Methods: A cross-sectional study had been done on 100 adult male patients with type 2 diabetes mellitus, attending endocrinology outpatient at Erbil Teaching Hospital between June and December 2021, and another 50 age-matched non-diabetic controls. Each one of them underwent detailed history taking, clinical examination, and relevant biochemical study.

Results: Sixty-three diabetic patients (63%) had erectile dysfunction compared to 6 nondiabetic subjects (12%). Mild, mild-to-moderate, moderate, and severe erectile dysfunction among these patients were 17 (27%), 21 (33.3%), 16 (25.4%), and 9 (14.3%), respectively. Among diabetics, erectile dysfunction was significantly associated with age, obesity, glycated hemoglobin level, duration of diabetes, presence of hypertension, dyslipidemia, and neuropathy (p= 0.001, 0.005, <0.001, 0.038, 0.02, 0.017 and 0.025 respectively)

Conclusion: Erectile dysfunction was significantly more prevalent in patients with type 2 diabetes than in non-diabetic patients. Being older than 50 years old, obesity, glycated hemoglobin level higher than 9, diabetes more than 10 years duration, presence of hypertension, dyslipidemia, and neuropathy were significantly in favor of a higher prevalence of erectile dysfunction in this group.

Downloads

Download data is not yet available.

References

Xu, Y., Zhang, Y., Yang, Y. et al. Prevalence and correlates of erectile dysfunction in type 2 diabetic men: a population-based cross-sectional study in Chinese men. Int J Impot Res 2019; 31, 9–14.

Anonymous. NIH consensus conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993;(270):83-90.

Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 1; 151(1): 54-61.

Fisher WA, Eardley I, McCabe M, et al. Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med. 2009;6(10):2746-60.

Salonia A, Castagna G, Saccà A, et al. Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function—Erectile function domain. The Journal of Sexual Medicine. 2012 1;9(10):2708-15.

Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. The Journal of urology. 1999 Jan;161(1):5-11.

Cander S, Coban S, Altuner S, et al. Prevalence and correlates of erectile dysfunction in type 2 diabetes mellitus: a cross-sectional single-center study among Turkish patients. Metabolic syndrome and related disorders. 2014 Aug 1;12(6):324-9.

Dan A, Chakraborty K, Mondal M, et al. Erectile dysfunction in patients with diabetes mellitus: Its magnitude, predictors and their bio-psycho-social interaction: A study from a developing country. Asian journal of psychiatry. 2014;7(1):58-65.

Corona G, Lee DM, Forti G, et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). The journal of sexual medicine. 2010 Apr 1;7(4):1362-80.

Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology. 2004 Dec 1;64(6):1196-201.

Nutalapati S, Ghagane SC, Nerli RB, Jali MV, Dixit NS. Association of erectile dysfunction and type II diabetes mellitus at a tertiary care centre of south India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 Jul 1;14(4):649-53.

Olamoyegun MA, Ala OA, Fagbemiro EY. Frequency and Determinants of Erectile Dysfunction among Type 2 Diabetes Patients in a Tertiary Health Institution in Nigeria. Journal of Advances in Medicine and Medical Research. 2020; 32(23):139-47.

Atlas D. International diabetes federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation. 2015: 10-17.

Sharifi F, Asghari M, Jaberi Y, Salehi O, Mirzamohammadi F. Independent predictors of erectile dysfunction in type 2 Diabetes mellitus: Is it true what they say about risk factors? ISRN Endocrinol. 2012;2012:502353.

Díaz-Díaz E., León M. C.,Arzuaga, et al. Erectile Dysfunction: A Chronic Complication of the Diabetes Mellitus. In: Nunes, K. P., editor. Erectile Dysfunction -Disease - Associated Mechanisms and Novel Insights into Therapy [Internet]. London: IntechOpen; 2012 [cited 2022 May 20]. Available from:https://www.intechopen.com/chapters/30219 doi: 10.5772/31005.

Johannes CB, Araujo AB, Feldman HA, et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. The Journal of urology. 2000 Feb;163(2):460-3.

Giugliano F, Maiorino M, Bellastella G, et al. Determinants of erectile dysfunction in type 2 diabetes. International Journal of Impotence Research. 2010 May;22(3):204-9.

Anonymous. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2014 Jan 1;37(1):81-90.

Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. The Aging Male. 2005 Jun 1;8(2):56-8.

Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International journal of impotence research. 1999 Dec;11(6):319-26.

Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007 Feb;120(2):151-7.

Rosen RC, Wing R, Schneider S, Gendrano N 3rd. Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am. 2005 Nov;32(4):403-17.

El-Latif MA, Makhlouf AA, Moustafa YM, et al. Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction. Int J Impot Res. 2006 Nov-Dec;18(6):544-9.

Nordin RB, Soni T, Kaur A, Loh KP, Miranda S. Prevalence and predictors of erectile dysfunction in adult male outpatient clinic attendees in Johor, Malaysia. Singapore Med J. 2019 Jan;60(1):40-7.

Skrypnik D, Bogda?ski P, Musialik K. Obesity--significant risk factor for erectile dysfunction in men. Pol Merkur Lekarski. 2014 Feb;36(212):137-41.

Momtaz YA, Hamid TA, Ibrahim R, Akahbar SA. Racial and socioeconomic disparities in sexual activity among older married Malaysians. Archives of gerontology and geriatrics. 2014 Jan 1;58(1):51-5.

Kovac JR, Labbate C, Ramasamy R, Tang D, Lipshultz LI. Effects of cigarette smoking on erectile dysfunction. Andrologia. 2015 Dec;47(10):1087-92.

Shiri R, Hakama M, Häkkinen J, et al. Relationship between smoking and erectile dysfunction. International journal of impotence research. 2005 Mar;17(2):164-9.

Kupelian V, Link CL, McKinlay JB. Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. European urology. 2007 Aug 1;52(2):416-22.

Wang XM, Bai YJ, Yang YB, et al. Alcohol intake and risk of erectile dysfunction: a dose-response meta-analysis of observational studies. Int J Impot Res. 2018 Nov;30(6):342-51.

Goslawski M, Piano MR, Bian JT, et al. Binge drinking impairs vascular function in young adults. Journal of the American College of Cardiology. 2013 Jul 16;62(3):201-7.

Leong DP, Smyth A, Teo KK, et al. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study. Circulation. 2014 Jul 29;130(5):390-8.

Binmoammar TA, Hassounah S, Alsaad S, Rawaf S, Majeed A. The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review. JRSM Open. 2016 Feb 12;7(3):2054270415622602.

Lu CC, Jiann BP, Sun CC, et al. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2009 Jun;6(6):1719-28.

Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. The journal of sexual medicine. 2010 Jan 1;7(1):156-65.

Doumas M, Douma S. The effect of antihypertensive drugs on erectile function: a proposed management algorithm. J Clin Hypertens (Greenwich). 2006 May;8(5):359-64.

Furukawa S, Sakai T, Niiya T, et al. Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study. Int J Impot Res. 2017 Jan;29(1):30-34.

Mota M, Lichiardopol C, Mota E, P?nu? C, P?nu? A. Erectile dysfunction in diabetes mellitus. Rom J Intern Med. 2003;41(2):163-77.

Meena BL, Kochar DK, Agarwal TD, Choudhary R, Kochar A. Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease. Int J Diabetes Dev Ctries. 2009 Oct;29(4):150-4.

Polonsky TS, Taillon LA, Sheth H, et al. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis. 2009 Dec;207(2):440-4.

Xu ZH, Pan D, Liu TY, et al. Effect of prolactin on penile erection: a cross-sectional study. Asian J Androl. 2019 Nov-Dec;21(6):587-91.

Kapoor D, Clarke S, Channer KS, Jones TH. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl. 2007 Dec;30(6):500-7.

Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005 Dec;90(12):6472-9.

Krassas GE, Tziomalos K, Papadopoulou F, Pontikides N, Perros P. Erectile Dysfunction in Patients with Hyper- and Hypothyroidism: How Common and Should We Treat? J Clin Endocrinol Metab 2008; 93(5): 1815–9.